MedPath

A medical records based study for the curative effect of combined traditional Chinese and western medicine in the treatment of severe novel coronavirus pneumonia (COVID-19)

Not Applicable
Recruiting
Conditions
ovel Coronavirus Pneumonia (COVID-19)
Registration Number
ITMCTR2000003220
Lead Sponsor
Affiliated Hospital of Guangdong Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

According to the clinical classification of the fifth edition of the national novel coronavirus pneumonia protocol, COVID 19 patients meet the standard

Exclusion Criteria

Patients younger than 18 years of age, older than 75 years of age, pregnant patients, patients with advanced malignancies, patients taking glucocorticoids during severe periods, patients taking other antiretroviral drugs, and those unwilling to sign informed consent

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
28-day mortality;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath